Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jul 15, 2024; 16(7): 3211-3229
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3211
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3211
Figure 8 A schematic model of the olfactomedin 4/nucleotide-binding oligomerization domain 1/caudal-type homeobox gene 2 pathway in gastric intestinal metaplasia cells and the mechanism of Weiwei Decoction in the treatment of gastric intestinal metaplasia through this pathway.
OLFM4: Olfactomedin 4; NOD1: Nucleotide-binding oligomerization domain 1; CDX2: Caudal-type homeobox gene 2; VIL1: Villin 1; KLF4: KLF transcription factor 4; WWD: Weiwei Decoction; MUC2: MUCIN 2.
- Citation: Zhou DS, Zhang WJ, Song SY, Hong XX, Yang WQ, Li JJ, Xu JQ, Kang JY, Cai TT, Xu YF, Guo SJ, Pan HF, Li HW. Weiwei Decoction alleviates gastric intestinal metaplasia through the olfactomedin 4/nucleotide-binding oligomerization domain 1/caudal-type homeobox gene 2 signaling pathway. World J Gastrointest Oncol 2024; 16(7): 3211-3229
- URL: https://www.wjgnet.com/1948-5204/full/v16/i7/3211.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i7.3211